Chondromodulin-I is an ideal target as it plays a critical role in Ewing sarcoma pathogenesis by being upregulated by the Ewing sarcoma fusion oncogene EWS-FLI1 and by maintaining an undifferentiated invasive phenotype and metastatic spread of the sarcoma cells. This evidence concerns the gene EWSR1 and Ewing sarcoma.